quote....."earnings from the third quarter include the impact of approx $2.6 million of pretax startup, expansion, and integration costs, or approx $1.7 million after tax." If you add this $1.7 million to the $4.8 mil of adjusted EPS you come up with $6.5 mil of "could have been" earnings. Divide that $6.5 mil by 66,460,000 outstanding shares and you come up with 9.8 cents per share. If it wasn't for those extra costs they would have earned a rounded 10 cents.
I sold a few weeks ago @ 10.55, but I'm still interested. Just thought I'd pass this info on as things aren't as bad as most seem to think.
HK is trading at a little over 2 X CASH FLOW. Ignore PE ratios in this business. Cash flow is the name of the game and how it relates to debt and capex.
If someone is careful afterhours they may be able to scoop up a few shares of this at a bargain price. I think it'll be higher tomorrow. I don't do AH trades.
J-man....good job.....Declares an EXTRA 5 cent dividend besides the .06 monthly. Nii was .24, but boosted by some extra stuff, still above the previous 1/4 if you eliminate the extra items. They had a huge gain on a closed position, made something like 5 X their investment (that gain isn't part of the jump in NII except for some interest received and fees).
Big jump in NAV as well.
Should be higher tomorrow.
I traded it twice for almost 2 X the div amount. Like you, I'd need something below $14.25 to get back in one more time.
You're nuts. This is nothing like DNDN. Their drug Provenge costs over $90,000 for a one time treatment. NAVB sells a diagnostics product that is just coming off the floor and has plenty of room to grow plus a great platform. No similarity whatsoever in my book.
J-man.......all depends on how much you buy. A few % of something in one's portfolio can't hurt anyone too much. Every risk I take is a calculated risk. I once held DNDN at about $4.20 cost and had it go from $7 up to $21 in one day. Needless to say I sold it immediately. That was in March - April of 2008. It subsequently went to $50 +.......now it's in the $2.50 area, hasn't ever split.
I haven't had any good luck w/ Precious Metals stocks in the last few years (KGC....CGR). Much better results w/ oils.
Tulsa........Saw one of your posts over there.
I added some at 1.55 today. Sales of Lymphoseek have to get moving, and quickly. Seems like a great product and platform. Could be a buyout candidate. Shares bought today more for trading than investment. Already have the "investment" shares, and they are obviously in the hole at this time. Not a big position, about 3.5% of my IRA account in total.
All big in diagnostics. All potential buyers of NAVB. What better time is there to buyout someone than when it's flat on its back. The lower the price, the lower the offer you can get away with. Think about it.
Lots of crude and refined product being exported. If we kept it all here, the price would be much lower, too low for E&P companies to do well.
For anyone interested. I started a thread over on that board. A few others have chimed in. Good NII of .36 and a small rise in NAV from 14.89 to 14.95. Raised a few concerns though. Three more months of unchanged dividends were declared.
Rub and Albi..........Here's what bothers me a little......
debt at 47% of Total Assets.........is at the top of the range for BDCs. Many are nearly as high, but some have ratios down in the 30 - 40% range or even less. It's OK as long as the economy staggers along, but in a recession it could be trouble. Don't forget......the investments that BDCs make are generally well below investment grade which is BBB- or better. Most BDC type holdings are probably single B (or less) or non rated. Make no mistake, these are aggressive investments that BDCs make. Several BDCs bit the dust, had to be merged, or slashed their dividends in the 2008 - 2011 time frame.
The realized loss was OK, that's part of the business (see above). I thought the unreaized gain that was booked was somewhat questionable as it seemed a little too convenient in that they came so close to offsetting one another. Without that gain the NAV would have taken a pretty hard hit.
My position is small, about 3.5% of my IRA account. I can live with that amount of risk. No other BDCs at this time, but I've held / traded numerous others. I do have a soft spot for the MONTHLY div payers.
5 analysts estimate an average of 8 cent loss....range of 7 - 9 cent loss....
Revenues......$970,000 average estimate....range of $300,000 - $2.5 million
**Revenue number at this time much more important that a penny one way or the other of earnings (loss).
The average estimate was 10 cents and they earned .07 (adjusted). Still margin concerns fro whatever reasons, plus the non core anchor.
Kel............sold awhile ago @ 10.55.....still watching